Matthew Philip Goetz, MD

  • 7781 Citations
  • 40 Scopus h-Index
20022021
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2002 2019

Filter
Article
2002
225 Citations (Scopus)

Painful metastases involving bone: Feasibility of percutaneous CT- and US-guided radio-frequency ablation

Callstrom, M. R., Charboneau, J. W., Goetz, M. P., Rubin, J., Wong, G. Y., Sloan, J. A., Novotny, P. J., Lewis, B. D., Welch, T. J., Farrell, M. A., Maus, T., Lee, R. A., Reading, C. C., Petersen, I. A. & Pickett, D. D., 2002, In : Radiology. 224, 1, p. 87-97 11 p.

Research output: Contribution to journalArticle

Radio
Neoplasm Metastasis
Bone and Bones
Pain
Analgesics
2003
17 Citations (Scopus)

A hot flash on tamoxifen metabolism

Goetz, M. P. & Loprinzi, C. L., Dec 3 2003, In : Journal of the National Cancer Institute. 95, 23, p. 1734-1735 2 p.

Research output: Contribution to journalArticle

Hormonal Antineoplastic Agents
Second-Generation Antidepressive Agents
Cyclohexanols
Hot Flashes
Selective Estrogen Receptor Modulators
38 Citations (Scopus)

Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, fluorouracil, and leucovorin in patients with solid tumors

Goetz, M. P., Erlichman, C., Windebank, A. J., Reid, J. M., Sloan, J. A., Atherton, P., Adjei, A., Rubin, J., Pitot, H. C., Galanis, E., Ames, M. M. & Goldberg, R. M., Oct 15 2003, In : Journal of Clinical Oncology. 21, 20, p. 3761-3769 9 p.

Research output: Contribution to journalArticle

irinotecan
oxaliplatin
Leucovorin
Fluorouracil
Appointments and Schedules
271 Citations (Scopus)

The Hsp90 chaperone complex as a novel target for cancer therapy

Goetz, M. P., Toft, D. O., Ames, M. M. & Erlichman, C., Aug 1 2003, In : Annals of Oncology. 14, 8, p. 1169-1176 8 p.

Research output: Contribution to journalArticle

tanespimycin
HSP90 Heat-Shock Proteins
Rifabutin
Neoplasms
Antineoplastic Agents
2004
8 Citations (Scopus)

Developments in combination chemotheraphy for colorectal cancer

Goetz, M. P. & Grothey, A. F., Aug 2004, In : Expert Review of Anticancer Therapy. 4, 4, p. 627-637 11 p.

Research output: Contribution to journalArticle

oxaliplatin
irinotecan
Colorectal Neoplasms
Combination Drug Therapy
Fluorouracil
14 Citations (Scopus)

Oxaliplatin plus oral fluoropyrimidines in colorectal cancer

Grothey, A. F. & Goetz, M. P., 2004, In : Clinical Colorectal Cancer. 4, SUPPL. 1

Research output: Contribution to journalArticle

oxaliplatin
irinotecan
Colorectal Neoplasms
Fluorouracil
Tegafur
400 Citations (Scopus)

Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: A multicenter study

Goetz, M. P., Callstrom, M. R., Charboneau, J. W., Farrell, M. A., Mans, T. P., Welch, T. J., Wong, G. Y., Sloan, J. A., Novotny, P. J., Petersen, I. A., Beres, R. A., Regge, D., Capanna, R., Saker, M. B., Grönemeyer, D. H. W., Gevargez, A., Ahrar, K., Choti, M. A., Debaere, T. J. & Rubin, J., 2004, In : Journal of Clinical Oncology. 22, 2, p. 300-306 7 p.

Research output: Contribution to journalArticle

Multicenter Studies
Neoplasm Metastasis
Bone and Bones
Pain
Opioid Analgesics
32 Citations (Scopus)

Primer on Medical Genomics Part XII: Pharmacogenomics - General Principles with Cancer as a Model

Goetz, M. P., Ames, M. M. & Weinshilboum, R. M., 2004, In : Mayo Clinic Proceedings. 79, 3, p. 376-384 9 p.

Research output: Contribution to journalArticle

Pharmacogenetics
Genomics
Pharmaceutical Preparations
Neoplasms
Drug-Related Side Effects and Adverse Reactions
2005
40 Citations (Scopus)

Clinical trial designs for prospective validation of biomarkers

Mandrekar, S. J., Grothey, A. F., Goetz, M. P. & Sargent, D. J., 2005, In : American Journal of PharmacoGenomics. 5, 5, p. 317-325 9 p.

Research output: Contribution to journalArticle

Biomarkers
Clinical Trials
Therapeutics
Patient Selection
Disease-Free Survival
14 Citations (Scopus)

CYP2D6 genotype and tamoxifen response.

Rae, J. M., Goetz, M. P., Hayes, D. F., Ingle, J. N., Li, L., Storniolo, A. M., Stearns, V. & Flockhart, D. A., 2005, In : Breast cancer research : BCR. 7, 5

Research output: Contribution to journalArticle

Hormonal Antineoplastic Agents
Postmenopause
Cytochrome P-450 CYP2D6
Tamoxifen
Genotype
648 Citations (Scopus)

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

Goetz, M. P., Rae, J. M., Suman, V. J., Safgren, S. L., Ames, M. M., Visscher, D. W., Reynolds, C., Couch, F. J., Lingle, W. L., Flockhart, D. A., Desta, Z., Perez, E. A. & Ingle, J. N., 2005, In : Journal of Clinical Oncology. 23, 36, p. 9312-9318 7 p.

Research output: Contribution to journalArticle

Hot Flashes
Pharmacogenetics
Cytochrome P-450 CYP2D6
Tamoxifen
Biotransformation
296 Citations (Scopus)

Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer

Goetz, M. P., Toft, D., Reid, J. M., Ames, M., Stensgard, B., Safgren, S., Adjei, A. A., Sloan, J. A., Atherton, P., Vasile, V., Salazaar, S., Adjei, A., Croghan, G. & Erlichman, C., Feb 20 2005, In : Journal of Clinical Oncology. 23, 6, p. 1078-1087 10 p.

Research output: Contribution to journalArticle

tanespimycin
Cytochrome P-450 CYP3A
Neoplasms
Maximum Tolerated Dose
Blood Cells
1 Citation (Scopus)

Targeted therapy for BRCA2 deficient tumors

Goetz, M. P. & Couch, F. J., Jul 2005, In : Cancer Biology and Therapy. 4, 7, p. 707-708 2 p.

Research output: Contribution to journalArticle

BRCA2 Protein
Frameshift Mutation
Poly(ADP-ribose) Polymerases
Enzyme Inhibitors
Apoptosis
2006
136 Citations (Scopus)

A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen

Goetz, M. P., Suman, V. J., Ingle, J. N., Nibbe, A. M., Visscher, D. W., Reynolds, C. A., Lingle, W. L., Erlander, M., Ma, X. J., Sgroi, D. C., Perez, E. A. & Couch, F. J., Apr 1 2006, In : Clinical Cancer Research. 12, 7 I, p. 2080-2087 8 p.

Research output: Contribution to journalArticle

Interleukin Receptors
Interleukin-17
Homeobox Genes
Tamoxifen
Gene Expression
9 Citations (Scopus)
Antineoplastic Combined Chemotherapy Protocols
Hand-Foot Syndrome
Taxoids
Erythema
Adjuvant Chemotherapy
142 Citations (Scopus)

Image-guided ablation of painful metastatic bone tumors: A new and effective approach to a difficult problem

Callstrom, M. R., Charboneau, J. W., Goetz, M. P., Rubin, J., Atwell, T. D., Farrell, M. A., Welch, T. J. & Maus, T., Jan 2006, In : Skeletal Radiology. 35, 1, p. 1-15 15 p.

Research output: Contribution to journalArticle

Bone and Bones
Neoplasms
Neoplasm Metastasis
Pain
Cryosurgery

In reply [2]

Goetz, M. P., Rae, J. M., Safgren, S. L., Ames, M. M., Visscher, D. W., Reynolds, C., Couch, F. J., Lingle, W. L., Flockhart, D. A., Desta, Z., Perez, E. A. & Ingle, J. N., Aug 1 2006, In : Journal of Clinical Oncology. 24, 22, p. 3709 1 p.

Research output: Contribution to journalArticle

154 Citations (Scopus)

Painful metastasis involving bone: Percutaneous image-guided cryoablation - Prospective trial interim analysis

Callstrom, M. R., Atwell, T. D., Charboneau, J. W., Farrell, M. A., Goetz, M. P., Rubin, J., Sloan, J. A., Novotny, P. J., Welch, T. J., Maus, T., Wong, G. Y. & Brown, K. J., Nov 2006, In : Radiology. 241, 2, p. 572-580 9 p.

Research output: Contribution to journalArticle

Cryosurgery
Neoplasm Metastasis
Bone and Bones
Pain
Analgesics
40 Citations (Scopus)

Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52

Ingle, J. N., Suman, V. J., Mailliard, J. A., Kugler, J. W., Krook, J. E., Michalak, J. C., Pisansky, T. M., Wold, L. E., Donohue, J. H., Goetz, M. P. & Perez, E. A., Jul 2006, In : Breast Cancer Research and Treatment. 98, 2, p. 217-222 6 p.

Research output: Contribution to journalArticle

Fluoxymesterone
Tamoxifen
Estrogen Receptors
Breast Neoplasms
Neoplasms
2007
39 Citations (Scopus)

A multidisciplinary approach to the management of breast cancer, part 1: Prevention and diagnosis

Pruthi, S., Brandt, K. R., Degnim, A. C., Goetz, M. P., Perez, E. A., Reynolds, C. A., Schomberg, P. J., Dy, G. K. & Ingle, J. N., 2007, In : Mayo Clinic Proceedings. 82, 8, p. 999-1012 14 p.

Research output: Contribution to journalArticle

Breast
Breast Neoplasms
Patient Care
Textbooks
Genetic Testing
24 Citations (Scopus)

A multidisciplinary approach to the management of breast cancer, part 2: Therapeutic considerations

Pruthi, S., Boughey, J. C., Brandt, K. R., Degnim, A. C., Dy, G. K., Goetz, M. P., Perez, E. A., Reynolds, C. A., Schomberg, P. J. & Ingle, J. N., 2007, In : Mayo Clinic Proceedings. 82, 9, p. 1131-1140 10 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Therapeutics
Pharmacogenetics
Tamoxifen
Standard of Care
1 Citation (Scopus)

Aromatase inhibitors and tamoxifen: Where do we go from here? Commentary

Goetz, M. P. & Loprinzi, C. L., Nov 2007, In : Nature Clinical Practice Oncology. 4, 11, p. 626-627 2 p.

Research output: Contribution to journalArticle

Aromatase Inhibitors
Tamoxifen
3 Citations (Scopus)

Early discontinuation of tamoxifen: A lesson for oncologists [3]

Goetz, M. P. & Ingle, J., Dec 1 2007, In : Cancer. 110, 11, p. 2595-2596 2 p.

Research output: Contribution to journalArticle

Hormonal Antineoplastic Agents
Treatment Refusal
Polypharmacy
Fluoxetine
Tamoxifen
5 Citations (Scopus)

Gene-expression-based predictors for breast cancer [17]

Goetz, M. P., Ingle, J. N. & Couch, F. J., Feb 15 2007, In : New England Journal of Medicine. 356, 7, p. 752 1 p.

Research output: Contribution to journalArticle

Local Neoplasm Recurrences
Genetic Models
Gene Expression Profiling
Survival Analysis
Oligonucleotide Array Sequence Analysis

Pemetrexed and oxaliplatin for metastatic colorectal cancer: results of a phase I Mayo Cancer Center Research Consortium trial, MC0248

Alberts, S. R., Kim, G. P., Mahoney, M. R., Gornet, M. K., Rubin, J., Ames, M., Goetz, M. P., Weinshilboum, R. M., Nicol, S. J. & Goldberg, R. M., 2007, In : Clinical Colorectal Cancer. 6, 8, p. 572-577 6 p.

Research output: Contribution to journalArticle

oxaliplatin
Pemetrexed
Maximum Tolerated Dose
Colorectal Neoplasms
Folic Acid
8 Citations (Scopus)

Phase II trial of oxaliplatin/irinotecan/5-fluorouracil/leucovorin for metastatic colorectal cancer

Mc Williams, R. R., Goetz, M. P., Morlan, B. W., Salim, M., Rowland, K. M., Krook, J. E., Ames, M. M. & Erlichman, C., 2007, In : Clinical Colorectal Cancer. 6, 7, p. 516-521 6 p.

Research output: Contribution to journalArticle

irinotecan
oxaliplatin
Leucovorin
Fluorouracil
Colorectal Neoplasms

Tamoxifen: Using pharmacogenetics to rediscover an old drug

Kamal, A. H. & Goetz, M. P., Oct 2007, In : Breast Cancer Online. 10, 10, e20.

Research output: Contribution to journalArticle

Pharmacogenetics
Tamoxifen
Cytochrome P-450 CYP2D6
Pharmaceutical Preparations
Aromatase Inhibitors
472 Citations (Scopus)

The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen

Goetz, M. P., Knox, S. K., Suman, V. J., Rae, J. M., Safgren, S. L., Ames, M. M., Visscher, D. W., Reynolds, C., Couch, F. J., Lingle, W. L., Weinshilboum, R. M., Fritcher, E. G. B., Nibbe, A. M., Desta, Z., Nguyen, A., Flockhart, D. A., Perez, E. A. & Ingle, J. N., Jan 1 2007, In : Breast Cancer Research and Treatment. 101, 1, p. 113-121 9 p.

Research output: Contribution to journalArticle

Cytochrome P-450 CYP2D6
Tamoxifen
Breast Neoplasms
Recurrence
Alleles
2008
21 Citations (Scopus)

Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: Combining inherited and tumor gene markers for prediction of tamoxifen resistance

Goetz, M. P., Suman, V. J., Couch, F. J., Ames, M. M., Rae, J. M., Erlander, M. G., Ma, X. J., Sgroi, D. C., Reynolds, C. A., Lingle, W. L., Weinshilboum, R. M., Flockhart, D. A., Desta, Z., Perez, E. A. & Ingle, J. N., Sep 15 2008, In : Clinical Cancer Research. 14, 18, p. 5864-5868 5 p.

Research output: Contribution to journalArticle

Interleukin Receptors
Cytochrome P-450 CYP2D6
Interleukin-17
Homeobox Genes
Tamoxifen
49 Citations (Scopus)

Molecular analysis of metaplastic breast carcinoma: High EGFR copy number via aneusomy

Gilbert, J. A., Goetz, M. P., Reynolds, C. A., Ingle, J. N., Giordano, K. F., Suman, V. J., Blair, H. E., Jenkins, R. B., Lingle, W. L., Reinholz, M. M., Adjei, A. & Ames, M. M., Apr 1 2008, In : Molecular Cancer Therapeutics. 7, 4, p. 944-951 8 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Breast Neoplasms
Mutation
Keratin-6
Keratin-5
133 Citations (Scopus)

Tamoxifen pharmacogenomics: The role of CYP2D6 as a predictor of drug response

Goetz, M. P., Kamal, A. & Ames, M. M., Jan 9 2008, In : Clinical Pharmacology and Therapeutics. 83, 1, p. 160-166 7 p.

Research output: Contribution to journalArticle

Cytochrome P-450 CYP2D6
Pharmacogenetics
Tamoxifen
Pharmaceutical Preparations
Estrogen Receptors
2009
412 Citations (Scopus)

Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen

Schroth, W., Goetz, M. P., Hamann, U., Fasching, P. A., Schmidt, M., Winter, S., Fritz, P., Simon, W., Suman, V. J., Ames, M. M., Safgren, S. L., Kuffel, M. J., Ulmer, H. U., Boländer, J., Strick, R., Beckmann, M. W., Koelbl, H., Weinshilboum, R. M., Ingle, J. N., Eichelbaum, M. & 2 others, Schwab, M. & Brauch, H., 2009, In : JAMA - Journal of the American Medical Association. 302, 13, p. 1429-1436 8 p.

Research output: Contribution to journalArticle

Cytochrome P-450 CYP2D6
Tamoxifen
Breast Neoplasms
Disease-Free Survival
Confidence Intervals

Endocrine therapy in 2009: Consideration of the tumor and the host

Goetz, M. P., Ames, M. M., Weinshilboum, R. M. & Ingle, J. N., Feb 2009, In : Oncology. 23, 2

Research output: Contribution to journalArticle

Hormonal Antineoplastic Agents
ErbB-2 Receptor
Selective Estrogen Receptor Modulators
Aromatase Inhibitors
Pharmacogenetics
1 Citation (Scopus)
Endangered Species
Medical Oncology
Research Personnel
Physicians
Selective Estrogen Receptor Modulators
Cytochrome P-450 CYP2D6
Precision Medicine
Medication Adherence
Tamoxifen
6 Citations (Scopus)

Tamoxifen, endoxifen, and CYP2D6: The rules for evaluating a predictive factor

Goetz, M. P., Dec 17 2009, In : Oncology. 23, 14

Research output: Contribution to journalArticle

Cytochrome P-450 CYP2D6
Tamoxifen
4-hydroxy-N-desmethyltamoxifen
167 Citations (Scopus)

The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor a for degradation in breast cancer cells

Wu, X., Hawse, J. R., Subramaniam, M., Goetz, M. P., Ingle, J. N. & Spelsberg, T. C., Mar 1 2009, In : Cancer Research. 69, 5, p. 1722-1727 6 p.

Research output: Contribution to journalArticle

Estrogen Receptor Modulators
Tamoxifen
Estrogen Receptors
Breast Neoplasms
Cytochrome P-450 CYP2D6
285 Citations (Scopus)

Trends in mastectomy rates at the Mayo Clinic Rochester: Effect of surgical year and preoperative magnetic resonance imaging

Katipamula, R., Degnim, A. C., Hoskin, T., Boughey, J. C., Loprinzi, C. L., Grant, C. S., Brandt, K. R., Pruthi, S., Chute, C. G., Olson, J. E., Couch, F. J., Ingle, J. N. & Goetz, M. P., Sep 1 2009, In : Journal of Clinical Oncology. 27, 25, p. 4082-4088 7 p.

Research output: Contribution to journalArticle

Mastectomy
Magnetic Resonance Imaging
Odds Ratio
Confounding Factors (Epidemiology)
Breast
2010
65 Citations (Scopus)

Clinical implementation of pharmacogenomics: Overcoming genetic exceptionalism

Relling, M. V., Altman, R. B., Goetz, M. P. & Evans, W. E., Jun 2010, In : The Lancet Oncology. 11, 6, p. 507-509 3 p.

Research output: Contribution to journalArticle

Cytochrome P-450 CYP2D6
Pharmacogenetics
Methyltransferases
Genetic Testing
Precursor Cell Lymphoblastic Leukemia-Lymphoma
98 Citations (Scopus)

Coprescription of tamoxifen and medications that inhibit CYP2D6

Sideras, K., Ingle, J. N., Ames, M. M., Loprinzi, C. L., Mrazek, D. P., Black, J. L., Weinshilboum, R. M., Hawse, J. R., Spelsberg, T. C. & Goetz, M. P., Jun 1 2010, In : Journal of Clinical Oncology. 28, 16, p. 2768-2776 9 p.

Research output: Contribution to journalArticle

Cytochrome P-450 CYP2D6
Tamoxifen
Breast Neoplasms
Recurrence
Enzymes
3 Citations (Scopus)
Hormonal Antineoplastic Agents
Aryl Hydrocarbon Hydroxylases
Cytochrome P-450 CYP2D6
Genetic Polymorphisms
Tamoxifen
146 Citations (Scopus)

Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors

Ingle, J. N., Schaid, D. J., Goss, P. E., Liu, M., Mushiroda, T., Chapman, J. A. W., Kubo, M., Jenkins, G. D., Batzler, A., Shepherd, L., Pater, J., Wang, L. M., Ellis, M. J., Stearns, V., Rohrer, D. C., Goetz, M. P., Pritchard, K. I., Flockhart, D. A., Nakamura, Y. & Weinshilboum, R. M., Nov 1 2010, In : Journal of Clinical Oncology. 28, 31, p. 4674-4682 9 p.

Research output: Contribution to journalArticle

Aromatase Inhibitors
Single Nucleotide Polymorphism
Genome
T-Cell Leukemia
Genome-Wide Association Study
38 Citations (Scopus)

Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer

Shah, S. M., Ketterling, R. P., Goetz, M. P., Ingle, J. N., Reynolds, C. A., Perez, E. A. & Chen, B., Jan 2010, In : Human Pathology. 41, 1, p. 103-106 4 p.

Research output: Contribution to journalArticle

Guidelines
Breast Neoplasms
Fluorescence In Situ Hybridization
erbB-1 Genes
Gene Amplification
3 Citations (Scopus)

Oncophenotypic review and clinical correlates of phosphatase and tensin homolog on chromosome 10 hamartoma tumor syndrome

Patnaik, M. M., Raza, S. S., Khambatta, S., Stanich, P. P. & Goetz, M. P., Dec 20 2010, In : Journal of Clinical Oncology. 28, 36

Research output: Contribution to journalArticle

Multiple Hamartoma Syndrome
PTEN Phosphohydrolase
Chromosomes, Human, Pair 10
Hamartoma
Phosphoric Monoester Hydrolases

Reply to S.L. Gomez et al

Goetz, M. P., Hoskin, T. L., Boughey, J. C. & Degnim, A. C., Apr 1 2010, In : Journal of Clinical Oncology. 28, 10

Research output: Contribution to journalArticle

1 Citation (Scopus)

Reply to T.A. James et al

Boughey, J. C., Goetz, M. P. & Degnim, A. C., Jul 20 2010, In : Journal of Clinical Oncology. 28, 21

Research output: Contribution to journalArticle

11 Citations (Scopus)

Synergistic interactions between aminoflavone, paclitaxel and camptothecin in human breast cancer cells

Reinicke, K. E., Kuffel, M. J., Goetz, M. P. & Ames, M. M., Aug 2010, In : Cancer Chemotherapy and Pharmacology. 66, 3, p. 575-583 9 p.

Research output: Contribution to journalArticle

aminoflavone
Camptothecin
Paclitaxel
Cells
Breast Neoplasms

Update on cyp2d6 and its impact on tamoxifen therapy

Goetz, M. P., Aug 2010, In : Clinical Advances in Hematology and Oncology. 8, 8, p. 536-538 3 p.

Research output: Contribution to journalArticle

Selective Estrogen Receptor Modulators
Cytochrome P-450 CYP2D6
Tamoxifen
Breast Neoplasms
Therapeutics
55 Citations (Scopus)

Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer

Ingle, J. N., Buzdar, A. U., Schaid, D. J., Goetz, M. P., Batzler, A., Robson, M. E., Northfelt, D. W., Olson, J. E., Perez, E. A., Desta, Z., Weintraub, R. A., Williard, C. V., Flockhart, D. A. & Weinshilboum, R. M., Apr 15 2010, In : Cancer Research. 70, 8, p. 3278-3286 9 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Estrogens
Androstenedione
Estrone
Testosterone
2011
20 Citations (Scopus)

Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence score

Kamal, A. H., Loprinzi, C. L., Reynolds, C., Dueck, A., Geiger, X. J., Ingle, J. N., Carlson, R. W., Hobday, T. J., Winer, E. P. & Goetz, M. P., 2011, In : Oncologist. 16, 10, p. 1359-1366 8 p.

Research output: Contribution to journalArticle

Breast
Recurrence
Genes
Oncologists
Drug Therapy